Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04706962
What this trial is testing

TH1902 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorTNBC - Triple-Negative Breast CancerHormone Receptor-positive Breast Cancer+7 more
Theratechnologies 70
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Large-scale testing (Phase 3)Study completedNCT04237090
What this trial is testing

Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel

Who this might be right for
Breast CancerLung CancerOvarian Cancer+4 more
Ciusss de L'Est de l'Île de Montréal 27
Testing effectiveness (Phase 2)Ended earlyNCT04383210
What this trial is testing

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more
Elevation Oncology 54
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Not applicableStudy completedNCT04000880
What this trial is testing

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

Who this might be right for
Breast CancerColorectal CancerEndometrial Cancer+6 more
University of Alabama at Birmingham 603
Post-approval studies (Phase 4)UnknownNCT05949424
What this trial is testing

OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults

Who this might be right for
Renal Cell CarcinomaOvarian CarcinomaThyroid Carcinoma+2 more
University Medical Center Groningen 30
Early research (Phase 1)Ended earlyNCT03861403
What this trial is testing

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Triple Negative Breast CancerAdvanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer+2 more
Leap Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Looking for participantsNCT04300556
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Who this might be right for
Solid Tumor
Eisai Inc. 182
Not applicableStudy completedNCT02910622
What this trial is testing

Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer.

Who this might be right for
Breast CancerOvarian Cancer
University Hospital, Limoges 30
Not applicableStudy completedNCT00972205
What this trial is testing

Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors

Who this might be right for
CervicalOvarianLung+2 more
National Cancer Institute (NCI) 12
Early research (Phase 1)WithdrawnNCT01386502
What this trial is testing

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Who this might be right for
Breast CancerColon CancerPancreatic Cancer+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01172028
What this trial is testing

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerEsophageal CancerGastric Cancer+4 more
University of Arizona 33
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Testing effectiveness (Phase 2)Study completedNCT02811497
What this trial is testing

Study of Azacitidine and Durvalumab in Advanced Solid Tumors

Who this might be right for
Microsatellite Stable Colorectal CarcinomaPlatinum Resistant Epithelial Ovarian Cancer Type IIEstrogen Receptor Positive and HER2 Negative Breast Cancer
University Health Network, Toronto 28
Not applicableLooking for participantsNCT07186296
What this trial is testing

EXoPERT EMERALD Clinical Study

Who this might be right for
Breast CancerColon CancerPancreatic Cancer+2 more
EXoPERT 1,400
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT03017573
What this trial is testing

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Who this might be right for
Ovarian CancerTriple-Negative Breast CancerHead and Neck Cancer+3 more
Institut Curie 1,050
Early research (Phase 1)WithdrawnNCT05431582
What this trial is testing

Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors

Who this might be right for
TumorsOvarian CancerBreast Cancer+2 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT03784859
What this trial is testing

Tissue Expansion in Breast Reconstruction Without Drains

Who this might be right for
Breast CancerHereditary Breast and Ovarian Cancer SyndromeBreast Implant; Complications
Cedars-Sinai Medical Center 5
Next Page